Transaction #10861 · Form 4 · 0001213900-25-113104
Silo Pharma, Inc. · Purchase · Common Stock
Silo Pharma, Inc. · Transacted November 19, 2025 · Filed November 20, 2025
What does this filing report?
An SEC Form 4 filing for Silo Pharma, Inc. records a purchase involving Common Stock on November 19, 2025. The reported quantity was 4,500. The filing date is November 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Silo Pharma, Inc.
- Company CIK
- 0001514183
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 4,500
- Reported price
- 0.405 · See footnotes
- Reference value
- 1,822.5
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 209,932
- Ownership description
- Not reported
- SEC acceptance time
- Nov 20, 2025, 4:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Weisblum Eric ↗
Chief Executive Officer · Director
CIK 0001569077
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2
- This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.